Federal marijuana protections safe for now with stopgap spending bill

“While we are pleased that these critical protections will continue, two weeks is not enough certainty for the millions of Americans who rely on medical marijuana,” said Rep. Earl Blumenauer.

 

President Donald Trump signed a stopgap spending bill Friday to avoid a government shutdown and keep the federal government running through Dec. 22.

Protections for state medical marijuana programs known as the Rohrabacher-Blumenauer amendment were also continued in the legislation to fund the government, Rep. Earl Blumenauer, D-Ore., announced in a statement Thursday after the House passed the measure.

“While we are pleased that these critical protections will continue, two weeks is not enough certainty for the millions of Americans who rely on medical marijuana for treatment and the businesses who serve them,” Blumenauer said. “As Congress works out a long-term funding bill, it must also include these protections. And ultimately, Congress must act to put an end to the cycle of uncertainty and permanently protect state medical marijuana programs — and adult use — from federal interference.”

 

The extension of Rohrabacher-Blumenauer comes a week after a letter was made public in which 66 members of Congress urged Senate and House leaders to extend the medical marijuana protections that have been in place since December 2014. Those protections, previously known as Rohrabacher-Farr, prohibit the U.S. Department of Justice from using federal funds to prevent certain states “from implementing their own State laws that authorize the use, distribution, possession or cultivation of medical marijuana.”

John Hudak

The likelihood of the Rohrabacher-Blumenauer amendment’s inclusion in a new omnibus bill is “pretty good,” said John Hudak, a drug policy specialist and senior fellow at the Brookings Institution in Washington, D.C., in an interview with The Cannabist earlier this week.

“We’ve been down this road before,” he said.

Although House members stymied efforts to include marijuana-related provisions — including Rohrabacher-Blumenauer — from the federal appropriations bill under consideration, there still exists avenues in the Senate for the insertion of Rohrabacher-Blumenauer, he added.

Additionally, stripping Rohrabacher-Blumenauer could have negative implications for Republicans’ efforts in trying to round up the necessary votes on the new tax bill, he said.

“It puts Congress in a position right now that if they start meddling significantly with upcoming spending legislation, it could put at risk this very fragile coalition that’s been put together on the tax bill,” Hudak said. “They probably have a lot more to lose by stripping it than they do to gain.”

The short-term continuing resolution should give Congress a few extra weeks to negotiate a broader omnibus appropriations bill that could then last for nine or 10 months, he said.

 

 

 

http://www.thecannabist.co/2017/12/07/federal-budget-medical-marijuana-rohrabacher-blumenauer/94177/

Annunci

ATTORNEY GENERAL JEFF SESSIONS MARIJUANA VIEWS FINDS RESISTANCE July 27, 2017

Since his confirmation as Attorney General on February 9th, 2017, rumors have swirled about Jeff Sessions and his justice department’s expected treatment of marijuana and the states where it is legal.

JUSTICE DEPARTMENT CONFUSED ABOUT JEFF SESSIONS MARIJUANA VIEWS

It is well known that the federal government does not view marijuana favorably and still does not believe there is any acceptable medical use for the plant. What we do not know concretely is how the new administration and justice department under Jeff Sessions will act on those archaic beliefs.

WHAT WAS SAID IN SESSIONS’ LETTER

According to reports, Mr. Sessions sent a letter to Congress in May asking for the removal of the Rohrabacher-Farr amendment from the next federal budget. The amendment protects medical marijuana states by disallowing the DEA from spending even a dime on prosecuting states where medical marijuana is legal.

 

threatens Marijuana state lawsSessions, stated “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime,” as his reasoning for the request.

MEDICAL MARIJUANA STILL HAS ITS SUPPORTERS

Luckily, for the sake and safety of many medical marijuana patients, the Senate recently struck down Sessions letter. The Senate appropriations committee decided that it would be wasteful and useless to spend federal government funds on prosecuting medical marijuana states due to the Attorney General’s pseudo-scientific views of marijuana.

Vermont Senator Patrick Leahy

One of the Senators on the appropriations committee, Patrick Leahy of Vermont stated, “I don’t want them spending money pursuing medical marijuana patients who are following state law, whether they’re an epileptic or whatever they might be.”

Senator Leahy is one of the many American citizens who believes that Sessions is overstepping his judicial duties in attempting to impose his personal views upon the civil liberties of millions of people. It’s been said before but it must continue to be said, Attorney General Jeff Sessions must either resign or openly state his confidence in the laws and regulations of the states when it comes to medical marijuana.

 

https://medicalmarijuana411.com/attorney-general-finds-resistance/?utm_source=newsletter120717&utm_medium=email&utm_campaign=dailydose&utm_content=readmore

CANNABIS IS BEST TREATMENT FOR POST-TRAUMATIC STRESS SYNDROME June 20, 2017

For far too long, people who suffer from post-traumatic stress syndrome have had to deal with the debilitating symptoms of the condition with little successful treatment. One treatment that is gaining increased popularity among veterans and other people with Post Traumatic Stress Disorder (PTSD), is the use of medical marijuana.

MARIJUANA MAY BE A LAST RESORT

Marijuana For PTSD TreatmentConsidering the fact that 20 veterans commit suicide every day in the United States, there is a clear need for a new form of treatment for people who suffer from PTSD.

As Dr. Sue Sisley, the psychiatrist who is leading the first randomized, controlled trial of the ability for cannabis to treat post-traumatic stress syndrome states, “I eventually started to see that a lot of these veterans were not responding to conventional medications, and then I began seeing a lot of deaths in my practice…these were people who had already been through the gauntlet of medications and nothing had helped.”

As Dr. Sisley explains, the traditional anti-depressants and anti-anxiety medications given to people with PTSD often end up causing more harm than help. Many veterans and others who have tried marijuana are actually able to slowly ween themselves off of the harsh mix of medications that they take on a daily basis.

WHY DOES MARIJUANA TREAT POST TRAUMATIC STRESS DISORDER?

The science behind why marijuana could help ease the effects of PTSD is actually very simple. One of the main symptoms of PTSD is an endocannabinoid deficiency. In people with PTSD, the body does not produce enough endocannabinoids to sufficiently fill cannabinoid receptors. Marijuana counteracts the symptoms of endocannabinoid deficiency by introducing cannabinoids from outside of the body that act as a replacement for the decreased production of cannabinoids in the body.

While there is overwhelming scientific and anecdotal evidence proving the efficacy of marijuana in treating post-traumatic stress syndrome, many people still don’t have access to it. For residents of Colorado however, that is changing.

COLORADO MAKES PTSD AN ELIGIBLE CONDITION

Colorado PTSD Cannabis TreatmentColorado lawmakers recently passed a bill making Colorado one of about 16 states which consider PTSD an eligible condition for treatment with medical marijuana. This huge step forward will finally allow Colorado citizens who suffer from PTSD to access the medicine they deem best fit to treat their condition. Hopefully more of the 29 states with established legal medical marijuana programs will consider the needs of veterans and others who have to live with PTSD and establish it as an accepted condition.While Colorado and other states are pushing forward by making PTSD an eligible condition for medical marijuana use, there are still many restrictions in place making it hard or even impossible for people to access the medicine they need. The fight must continue until everyone with PTSD has the chance to treat their condition with the safest and most effective medicine possible.

 

 

https://medicalmarijuana411.com/marijuana-treating-ptsd/?utm_source=newsletter120717&utm_medium=email&utm_campaign=dailydose&utm_content=readmorereadmore

HOUSTON D.A SAYS IT “DOESN’T MAKE SENSE” TO PROSECUTE MARIJUANA OFFENSES January 11, 2017

“I’VE NEVER FELT GOOD ABOUT PUTTING MARIJUANA USERS IN THE SAME JAIL CELLS AS MURDERERS,” – HOUSTON D.A

Houston D.A Says It “Doesn’t Make Sense” To Prosecute Marijuana Offenses- The State of Texas as a whole is one of the most anti-marijuana states. The state does offer medical marijuana for those suffering from intractable epilepsy and other chronic diseases after passing the Compassionate Use Act in June 2015. However, those caught using or distributing marijuana without the proper identification can still face charges for carrying even the smallest amounts of weed.

Currently, in Texas, persons found with less than two ounces of marijuana can face a misdemeanor charge and up to 180 days in jail. Perpetrators caught with between two and four ounces of pot may be sentenced to at least a year in jail, while those caught with more than four ounces of marijuana face felony charges and jail sentences between two and 99 years.

HOUSTON TEXAS

Kim Ogg – the newly elected District Attorney of Houston’s New Harris County

In Houston marijuana is illegal, but the enforcement of the the law is changing. Last week, Kim Ogg – the newly elected District Attorney of Houston’s New Harris County vowed to uphold her campaign promise to reform marijuana laws.

enforcers want to enforce the law differently. Last week, Kim Ogg – the newly elected District Attorney of Houston’s New Harris County – vowed to uphold her campaign promise to reform marijuana laws. From Kim Oggs campaign site ‘Ogg’s marijuana platform reflects common sense drug prosecution policies that mirror the concerns of ordinary citizens who are tired of hearing that the police and prosecutors don’t have the time to investigate and prosecute home burglaries, or the resources to test backlogged rape kits. Ogg’s plan is to increase public safety by keeping law enforcement on the street instead of wasting time arresting those in possession of small amounts of marijuana.’

“Gangs and organized crime groups are running rampant in Harris County, and I want law enforcement to have the time and money necessary to dismantle those operations. Every time they arrest someone in possession of marijuana, police are off the streets for an average of four hours.” — Kim Ogg

“I’ve never felt good about putting marijuana users in the same jail cells as murderers,” Ogg said after being sworn into office last Monday. “It’s just not fair, it doesn’t make any sense, and our country is resoundingly against that.”So she vows to ensure that “all misdemeanor possession of marijuana cases will be diverted around jail.”

Houston’s new Police Chief, Art Acevedo, added that steps toward decriminalization could open the door to legalizing medical marijuana in Texas.

Houston’s new Police Chief, Art Acevedo

“I think you’ll have a really spirited but well-informed discussion, and at some point I could really foresee, in the future, marijuana and some other oils being legalized for medicinal purposes,” Chief Acevedo said. “It will probably be the first step in Texas.”

 

 

https://medicalmarijuana411.com/da-says-doesnt-make-sense-prosecute-marijuana-offenses/?utm_source=newsletter120717&utm_medium=email&utm_campaign=dailydose&utm_content=readmore

Ridete! Fa bene alla salute, aiuta a bruciare calorie e ad essere più efficienti sul lavoro

MetropoliZ blog

articolo di Valentina Arcovio
È scientificamente dimostrato: migliora la circolazione del sangue, previene le malattie cardiovascolari, tiene il cervello allenato, contrasta ansia e depressione e contribuisce alla salute del sistema immunitario
C’è un modo semplice ed economico per vivere di più e meglio: ridere. E’ infatti scientificamente dimostrato che ridere è una sorta di elisir che allunga e migliora la nostra vita. E non c’è giorno migliore di questo, che è la Giornata mondiale della risata, per imparare o riprendere a farlo. Proprio come se fosse una medicina o almeno così la considerano esperti e scienziati provenienti da ogni parte del mond o, il cui parere è stato analizzato da uno studio condotto da Espresso Communication su oltre 70 testate internazionali.
RIDERE ALLENA IL CERVELLO E PREVIENE LE MALATTIE CARDIOVASCOLARI

La Giornata mondiale della risata è nata nel 1998 come manifestazione a favore della pacesu iniziativa del medico indiano…

View original post 959 altre parole

Kentucky is already a marijuana state; we just have chosen the least effective way to manage that fact…

U.S. Marijuana Party Kentucky

GUEST OP-ED: Time to rethink Kentucky’s marijuana laws

100-seeds-Semen-Fructus-font-b-Cannabis-b-font-font-b-Cannabis-b-font-sativa-font

  • David Adams/Guest Op-Ed
  • Kentucky is already a marijuana state; we just have chosen the least effective way to manage that fact, causing incalculable harm and missing practically all the benefits of embracing a natural advantage at our fingertips.

    As our nation quickly approaches three dozen states with at least some form of legal marijuana production, our Commonwealth wastes money chasing people it can’t catch growing a medical crop it mostly can’t benefit from, serving a decades old propaganda scheme it doesn’t really take seriously. People with epilepsy, PTSD, multiple sclerosis, depression, cancer and arthritis seeking relief with cannabis risk not only arrest attempting to make a purchase, they face uncertain quality or effectiveness from sources stuck in the shadows while residents of three neighboring states already benefit from well established science ensuring results and safety.

    Spending limited available police resources hunting marijuana…

    View original post 496 altre parole

    Who Should Support Kentucky’s Efforts to Legalize Cannabis?

    U.S. Marijuana Party Kentucky

    OUR FRIENDS AT “KCFC” ARE WORKING HARD TO MAKE KENTUCKY A “LAWFUL” STATE!PLEASE SUPPORT THEM IN THEIR JOURNEY TO PROCURE THE FREEDOM OF CANNABIS IN OUR STATE!

    Who Should Support Kentucky’s Efforts to Legalize Cannabis?

    When I expressed my excitement about Sen. Perry Clark filing the Kentucky Cannabis Freedom Act, a bill to end Kentucky’s prohibition on marijuana, a colleague of mine had this response, “It doesn’t even matter. The only people who would support that are stoner losers who are too lazy to even vote.” The generalizations in those twenty words summed up the total lack of understanding most people have about cannabis and why this legislation is so important to our state, and the nation as a whole. So here’s what I think about who should support this bill, and why. CONTINUE READING…

    View original post

    You Can Now ‘Snort’ Weed Using This Cannabis Nasal Spray

    When listing off drugs you can snort up your nose, marijuana usually doesn’t make the list. But with cannabinoid-spiked nasal sprays, that’s now possible, though it might not be any different than smoking. Homemade cannabis nasal sprays have existed on the fringes of the medical weed market for years now, but a Colorado company recently…

    Sorgente: You Can Now ‘Snort’ Weed Using This Cannabis Nasal Spray

    JAMA Neurology study delivers verdict on novel MS treatment

    A new study published by JAMA Neurology delivers a verdict on a long-debated theory that MS can be treated by opening blocked veins: it’s safe but “largely ineffective,” and so cannot be recommended.

    The treatment didn’t reduce the patients’ disability and only restored brain blood flow in about half of patients, according to lead author Dr. Paolo Zamboni and a committee of neurologists based in Italy.
    Dr. Zamboni was the originator of the theory. He first proposed in 2009 that blocked veins might lead to some of the symptoms of MS. That set off a firestorm of interest by patients and scientists about the possibility that the disease, long labelled an immune disorder, could be linked to vein abnormality a condition Dr. Zamboni dubbed Chronic Cerebrospinal venous insufficiency, or CCSVI.

    The JAMA study, dubbed “Brave Dreams,” was designed to help answer the question: Could opening up those abnormal veins improve symptoms associated with MS?
    The study was designed to be a large one, funded to treat 430 MS patients with either balloon angioplasty to open narrowed veins, or a placebo procedure.
    However, after several years, researchers recruited only 115 patients.
    The study reports that only six of the 15 MS clinics and centres that had agreed to participate in the study actually did.
    Some patients in the study were reluctant to participate, unwilling to risk being in the placebo group and not receive the treatment.
    “This was very tough for us,” Dr. Zamboni told CTV News.
    “Really the neurological community, asked for a double-blinded study, but in the meantime the neurologists rarely supported the study.”
    All of the patients in the study were diagnosed with CCSVI on ultrasound and with angiograms.
    Balloon angioplasty corrected or restored blood flow in 53 per cent of patients treated for blocked veins. But it didn’t seem to work on the others.
    When scientists compared the effects on disability scores and brain scans, they reported no differences between the placebo and treatment groups.
    “It’s an unusual study,” said Dr. George Ebers, a now-retired Canadian neurologist from Oxford University, who was asked to comment on the paper.
    “You’ve got a study designed for some 400 people only able to enroll about 100. So it means it was very much underpowered to answer the questions. Yet it came up with this conclusion.”
    Despite the limitations in the study, he agreed with its conclusions.
    “No one in the scientific world thought there were legs to this idea. I couldn’t see any rationale to support the idea that venous narrowing is linked to MS,” he said.

    Dott.ssa Maria Grazia Piscalgia

    Dr. Maria Grazia Piscalgia, a neurologist in Ravenna, Italy, referred 28 of the 115 patients to the Brave Dreams study.
    She told CTV News that eight of those patients received placebo angioplasty, while 20 were given the balloon angioplasty.
    Of those 20 who received the treatment, 18 showed improvements in symptoms and fewer lesions on MRI scans for one year.
    However, the data, when combined with all the other patients studied, showed no overall benefit.

    “I believe that research in medicine, even if it leads to negative results, allows us to understand the diseases and care more precisely for the people who suffer from it,” Dr. Piscaglia said in an email.

    While clearly the therapy doesn’t work on all patients, the study does note there appears to be a group of patients, who had fewer brain lesions, suggesting this group should be “further analyzed.”
    That research that could potentially explain cases like Tammy Lynn Tremblay. She was diagnosed with MS in 2006, and began losing strength, balance and vision.

    Tammy Lynn Tremblay

    “I would end up in a wheelchair. It was scary — very scary,” she said.
    When drugs didn’t stop her decline, the Ottawa scientist researched Zamboni’s theory and went to Poland in 2010 for angioplasty, to open up blocked veins.
    “The great thing is that I have never had any other MS episodes since and this was 2010. So, after seven years, if this is a placebo effect, it’s a pretty good one.”

    Tremblay still holds out hope for her future.
    “There is no cure for MS,” she said. “I would still encourage them to pursue and investigate this possible avenue.”

     

     

     

    http://www.ctvnews.ca/health/jama-neurology-study-delivers-verdict-on-novel-ms-treatment-1.3684387